28 Jul. 2023

Histopathology Platform - Junior Digital Pathology Scientist

Institutional
Application Starts: 01 Aug. 2023
Application Ends: 05 Aug. 2023

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Junior Digital Pathology Scientist to join our Histopathology Platform team, at the Champalimaud Research Programme. 

The selected candidate will

Work closely with senior experimental pathologists and laboratory staff to support a variety of research projects, in the field of digital pathology. Responsibilities will include:

01 August 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 6

Since 2012, August 1 has been designated as World Lung Cancer Day. The international lung health community uses the day to raise awareness and spread information about the disease’s risk factors, symptoms, diagnosis and treatment.

Dr. Susana Simões, of the Champalimaud Foundation’s Lung Unit, joined us for a conversation about this disease, which is responsible for more cancer deaths than any other.

12 July 2023

Check Up #15 - What is therapeutic Nuclear Medicine

In CheckUp #14, we talked about the different types of cancer treatments with ionizing radiation: internal and external radiotherapies. We promised we would return to this subject to talk in more detail about a special type of internal radiotherapy: molecular radiotherapy. This activity is integrated in Nuclear Medicine, a medical specialty that, in Oncology, uses radiopharmaceuticals to diagnose, treat, and evaluate the response of cancers to existing or new drugs.

21 June 2023

One big problem with the detection of prostate cancer is that it is purely based on the visual perception of radiologists looking at MRI exams

Interview with Nikos Papanikolaou, principal investigator of the Computational Clinical Imaging Group.

João Goulão

Diana Miguel

Maria Sanches

Miguel Correia

Markus Büchler

Subscribe to Cancer
Loading
Please wait...